Adalimumab (humira) For The Treatment Of Refractory Sight-threatening Non-infectious Uveitis: One Year Outcomes Of An Open-label Prospective Multicenter Study.

E Suhler, Careen Lowder, Debra Goldstein, Tracy Giles, Howard Tessler, Andreas Lauer, Justine Smith, J Rosenbaum

    Research output: Contribution to conferencePaper

    Original languageEnglish
    Publication statusPublished - 2011
    EventAssociation for Research in Vision and Ophthalmology (ARVO) 2011 -
    Duration: 1 Jan 2011 → …

    Conference

    ConferenceAssociation for Research in Vision and Ophthalmology (ARVO) 2011
    Period1/01/11 → …

    Cite this

    Suhler, E., Lowder, C., Goldstein, D., Giles, T., Tessler, H., Lauer, A., Smith, J., & Rosenbaum, J. (2011). Adalimumab (humira) For The Treatment Of Refractory Sight-threatening Non-infectious Uveitis: One Year Outcomes Of An Open-label Prospective Multicenter Study.. Paper presented at Association for Research in Vision and Ophthalmology (ARVO) 2011, .